Cardio-Oncology
There is no content available at this time. Please check again later.
Relevant Content
Cluster Randomized Trial of Intensive Systolic Blood Pressure Control in Patients With Renal Cell or Thyroid Cancer Receiving VEGFR Tyrosine Kinase Inhibitors: ECOG-ACRIN EAQ191
Guideline-Directed Treatment of Venous Thromboembolism (VTE) Including Special Populations
Evaluating the Patient with VTE
Optimizing the Diagnosis and Treatment of Venous Thromboembolism (VTE)
Carfilzomib-Induced Cardiogenic Shock: A Reversible But Life-Threatening Complication
Hypertension, Ahead of Print.
BACKGROUND:The objective of this cluste...
Kinetics of Technetium-Labeled Cardiac Amyloid Radionuclide Imaging
BACKGROUND:The objective of this cluste...
Circulation: Cardiovascular Imaging, Ahead of Print.
BACKGROUND:Techn...
Restarting Immune Checkpoint Inhibitors After ICI Myocarditis: A Prospective Cohort
BACKGROUND:Techn...
Circulation, Volume 153, Issue 14, Page 1079-1081, April 7, 2026.
Letter by Liu and Li Regarding Article, “Ponatinib, But Not the New Abl-Kinase Inhibitor Asciminib, Activates Platelets, Leukocytes, and Endothelial Cell TNF Signaling to Induce Atherosclerotic Plaque Inflammation, Myocardial Infarction, and Stroke”
Circulation, Volume 153, Issue 14, Page e1107-e1108, April 7, 2026.
Safety and Treatment Efficacy of Systemic, Locoregional, and Nanoparticle Encapsulated Anthracycline Chemotherapy: Insights Into Cardiotoxicity
Arteriosclerosis, Thrombosis, and Vascular Biology, Ahead of Print.
C...
Unleashing the Power of Multidisciplinary Teams in VTE Treatment
C...
Circulation: Heart Failure, Ahead of Print.